• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

住院和非住院受试者中念珠菌属频率的评估。

Evaluation of the frequency of Candida spp. in hospitalized and non-hospitalized subjects.

作者信息

Vieira J N, Feijó A M, Bueno M E, Gonçalves C L, Lund R G, Mendes J F, Villarreal J P V, Villela M M, Nascente P S

机构信息

Laboratório de Parasitologia, Instituto de Biologia, Departamento de Microbiologia e Parasitologia, Universidade Federal de Pelotas - UFPEL, Campus universitário Capão do Leão, s/n, Prédio 18, Sala 3, CEP 96010-900, Pelotas, RS, Brazil.

Departamento de Odontologia Restauradora, Faculdade de Medicina Dentária, Universidade Federal de Pelotas - UFPEL, Rua Gonçalves Chaves, nº 457, Centro, CEP 96020-080, Pelotas, RS, Brazil.

出版信息

Braz J Biol. 2018 Nov;78(4):644-652. doi: 10.1590/1519-6984.169623. Epub 2018 Feb 15.

DOI:10.1590/1519-6984.169623
PMID:29451605
Abstract

The aim of this study was to evaluate the frequency of Candida species between a non-hospitalized and a hospitalized population. For this purpose, samples of saliva were sampled through sterile swabs, moistened in peptone water and rubbed in the oral cavity of 140 individuals, from which, 70 were hospitalized patients from the Medical Clinic of a Teaching Hospital and the other 70 were non-hospitalized subjects. All saliva samples were plated in Sabouraud Dextrose agar added with Chloramphenicol and incubated at 36 °C for 48 hours. The morphology identification was performed through macroscopic and microscopic characterization, the CHROMagar Candida medium and the VITEK® system Yeast Biochemical Card (bio Mérieux SA, France). The results showed a colonization of Candida spp. in 85.7% the hospitalized individuals, where the species found were C. albicans (60%), C. tropicalis (23.4%), C. krusei (3.3%) and Candida spp. (13.3%). In the non-hospitalized individuals the colonization by Candida spp was 47.1%, and the species found were: C. albicans (45.5%), C.krusei (9.1%), C. guilliermondii (9.1% %), C. tropicalis (3.0%), C. famata (3.0%) and Candida spp. (30.3%). In spite of their presence in oral cavity in both groups, Candida spp. was more frequently isolated in hospitalized individuals, who were 6.73 times more likely to have this fungus in the oral cavity and were 3.88 times more likely to have Candida albicans.

摘要

本研究的目的是评估非住院人群和住院人群中念珠菌属的感染频率。为此,通过无菌拭子采集唾液样本,将拭子在蛋白胨水中浸湿后在140名个体的口腔中擦拭,其中70名是一家教学医院内科诊所的住院患者,另外70名是非住院受试者。所有唾液样本均接种于添加氯霉素的沙氏葡萄糖琼脂平板上,在36℃孵育48小时。通过宏观和微观特征、CHROMagar念珠菌培养基和VITEK®系统酵母生化鉴定卡(法国生物梅里埃公司)进行形态学鉴定。结果显示,85.7%的住院个体有念珠菌属定植,其中发现的菌种为白色念珠菌(60%)、热带念珠菌(23.4%)、克柔念珠菌(3.3%)和念珠菌属(13.3%)。在非住院个体中,念珠菌属的定植率为47.1%,发现的菌种为:白色念珠菌(45.5%)、克柔念珠菌(9.1%)、季也蒙念珠菌(9.1%)、热带念珠菌(3.0%)、法塔念珠菌(3.0%)和念珠菌属(30.3%)。尽管两组人群口腔中均有念珠菌属存在,但住院个体中念珠菌属的分离频率更高,其口腔中有这种真菌的可能性是非住院个体的6.73倍,感染白色念珠菌的可能性是非住院个体的3.88倍。

相似文献

1
Evaluation of the frequency of Candida spp. in hospitalized and non-hospitalized subjects.住院和非住院受试者中念珠菌属频率的评估。
Braz J Biol. 2018 Nov;78(4):644-652. doi: 10.1590/1519-6984.169623. Epub 2018 Feb 15.
2
Evaluation of a commercial medium for identification of Candida species.用于鉴定念珠菌属菌种的一种商业培养基的评估
Eur J Clin Microbiol Infect Dis. 1996 Feb;15(2):153-8. doi: 10.1007/BF01591489.
3
Direct isolation of Candida spp. from blood cultures on the chromogenic medium CHROMagar Candida.在显色培养基CHROMagar念珠菌上直接从血培养物中分离念珠菌属。
J Clin Microbiol. 2003 Jun;41(6):2629-32. doi: 10.1128/JCM.41.6.2629-2632.2003.
4
Cost-effectiveness and efficacy of CHROMagar Candida medium in clinical specimens.CHROMagar念珠菌培养基在临床标本中的成本效益及有效性
East Mediterr Health J. 2000 Sep-Nov;6(5-6):968-78.
5
Comparative study of Candida by conventional and CHROMagar method in non-denture and denture wearers by oral rinse technique.采用口腔冲洗技术,通过传统方法和科玛嘉方法对无牙颌佩戴者和戴假牙者的念珠菌进行比较研究。
Indian J Dent Res. 2012 Jul-Aug;23(4):490-7. doi: 10.4103/0970-9290.104956.
6
Evaluation of CHROMagar Candida for rapid screening of clinical specimens for Candida species.评估科玛嘉念珠菌显色培养基用于临床标本中念珠菌属快速筛查的效果。
Mycoses. 1999 Apr;42(1-2):61-5. doi: 10.1046/j.1439-0507.1999.00406.x.
7
Evaluation of risk factors in patients with vulvovaginal candidiasis and the value of chromID Candida agar versus CHROMagar Candida for recovery and presumptive identification of vaginal yeast species.评估外阴阴道假丝酵母菌病患者的危险因素,以及 ChromID Candida 琼脂与 CHROMagar Candida 在阴道酵母菌种的分离和鉴定中的应用价值。
Med Mycol. 2011 Jan;49(1):16-25. doi: 10.3109/13693786.2010.497972. Epub 2010 Jul 7.
8
Identification of local clinical Candida isolates using CHROMagar Candida™ as a primary identification method for various Candida species.使用科玛嘉念珠菌显色培养基(CHROMagar Candida™)作为对多种念珠菌属进行初步鉴定的方法来鉴定本地临床念珠菌分离株。
Trop Biomed. 2011 Aug;28(2):269-74.
9
Role of Non-Albicans Candida and Candida Albicans in Oral Squamous Cell Cancer Patients.非白色念珠菌和白色念珠菌在口腔鳞状细胞癌患者中的作用。
J Oral Maxillofac Surg. 2018 Dec;76(12):2564-2571. doi: 10.1016/j.joms.2018.06.012. Epub 2018 Jun 14.
10
Incidence rate of Candida species in the oral cavity of middle-aged and elderly subjects.中老年受试者口腔念珠菌属的发病率
Adv Med Sci. 2006;51 Suppl 1:233-6.

引用本文的文献

1
Risk of oral candidiasis: profile analysis of patients admitted to the dermatology clinic of a tertiary hospital in southeast of Brazil.口腔念珠菌病的风险:对巴西东南部一家三级医院皮肤科门诊收治患者的剖析
Rev Inst Med Trop Sao Paulo. 2025 Aug 18;67:e54. doi: 10.1590/S1678-9946202567054. eCollection 2025.
2
Antimicrobial and antiparasitic potential of lupeol: antifungal effect on the species complex and nematicidal activity against .羽扇豆醇的抗菌和抗寄生虫潜力:对该物种复合体的抗真菌作用及对……的杀线虫活性
J Med Microbiol. 2025 Mar;74(3). doi: 10.1099/jmm.0.001976.
3
Update of the list of QPS-recommended biological agents intentionally added to food or feed as notified to EFSA 9: suitability of taxonomic units notified to EFSA until September 2018.
截至2018年9月通知欧洲食品安全局(EFSA)的有意添加到食品或饲料中的QPS推荐生物制剂清单更新:向EFSA通报的分类单元的适用性
EFSA J. 2019 Jan 24;17(1):e05555. doi: 10.2903/j.efsa.2019.5555. eCollection 2019 Jan.